These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 27793006)
21. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling. Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419 [TBL] [Abstract][Full Text] [Related]
22. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer. Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160 [TBL] [Abstract][Full Text] [Related]
23. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques. Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860 [TBL] [Abstract][Full Text] [Related]
24. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
25. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer. Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118 [TBL] [Abstract][Full Text] [Related]
26. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271. Li N; Wang C; Zhang P; You S Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876 [TBL] [Abstract][Full Text] [Related]
27. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
28. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027 [TBL] [Abstract][Full Text] [Related]
29. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways. Zhang L; Zhou J; Qin X; Huang H; Nie C Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841 [TBL] [Abstract][Full Text] [Related]
30. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor. Jung KH; Zheng HM; Jeong Y; Choi MJ; Lee H; Hong SW; Lee HS; Son MK; Lee S; Hong S; Hong SS Cancer Lett; 2013 Jan; 328(1):176-87. PubMed ID: 22902995 [TBL] [Abstract][Full Text] [Related]
31. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
32. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131 [TBL] [Abstract][Full Text] [Related]
33. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Park CY; Son JY; Jin CH; Nam JS; Kim DK; Sheen YY Eur J Cancer; 2011 Nov; 47(17):2642-53. PubMed ID: 21852112 [TBL] [Abstract][Full Text] [Related]
34. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
35. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
36. A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells. Ischenko I; Petrenko O; Hayman MJ Oncotarget; 2015 Jun; 6(18):15814-27. PubMed ID: 26158412 [TBL] [Abstract][Full Text] [Related]
37. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
38. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells. Qin Y; Zhang Q; Lee S; Zhong WL; Liu YR; Liu HJ; Zhao D; Chen S; Xiao T; Meng J; Jing XS; Wang J; Sun B; Dai TT; Yang C; Sun T; Zhou HG Oncotarget; 2015 Dec; 6(38):40667-79. PubMed ID: 26512779 [TBL] [Abstract][Full Text] [Related]
39. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma. Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer. Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]